Enzo Health raises $20M Series A

Home health software is having a moment — because the care system around older Americans is getting squeezed from every side. More patients want treatment and recovery at home. But the agencies delivering that care are buried in documentation, reimbursement rules, and staffing shortages. That is the gap Enzo Health is trying to fill, and on May 4 the Lehi, Utah startup said it raised a $20 million Series A led by N47, bringing total funding to $26 million. ### What does Enzo actually sell? Enzo is not a home-care provider. It sells software to the agencies and post-acute operators that run home health workflows. The pitch is an AI-native system that handles intake, clinical documentation, quality assurance, compliance checks, referral workflows, and reimbursement-related tasks in one place instead of forcing teams to bounce between separate tools. (prnewswire.com) ### Why is that useful now? Because home health is one of those sectors where the work is both human and brutally administrative. Nurses and clinicians are supposed to care for patients, but a huge share of their day disappears into forms, billing logic, eligibility checks, and regulatory documentation. Enzo’s whole argument is that the real bottleneck is not just a labor shortage — it is labor being eaten by paperwork. (prnewswire.com) ### Why are investors leaning in? The aging-demand story is the obvious part. Enzo and industry outlets point to the same pressure wave — more than 10,000 Americans turning 65 each day, with home-based care demand climbing fast. If more recovery, chronic care, and end-of-life care move into the home, the software layer that keeps agencies compliant and paid becomes more valuable. Basically, investors are backing the plumbing. (prnewswire.com) ### What makes this raise stand out? The headline number is $20 million, but the more telling detail is the traction Enzo attached to it. The company says it grew revenue by more than 40x in its first 12 months and is now used by organizations supporting more than 500,000 patients a year. Those are company-reported numbers, so they deserve some caution, but they explain why a specialist workflow startup could pull a sizable Series A so quickly after launching in 2024. (prnewswire.com) ### Where does the money go? Not into opening clinics. Into expanding the software across more of the post-acute stack. Enzo says the new capital will help it deepen its home-health product and move into skilled nursing and hospice care — adjacent settings that suffer from many of the same workflow, staffing, and compliance headaches. That matters because it turns Enzo from a point solution into a broader post-acute operating layer. (prnewswire.com) ### Why not just use legacy healthcare software? That is the industry frustration Enzo is attacking. Older systems often split intake, charting, quality review, and back-office functions across multiple products. Agencies end up stitching together a patchwork. The catch is that every handoff creates extra clicks, duplicate work, and more room for denials or audit trouble. Enzo’s bet is that a single AI-first stack can remove enough friction to protect margins and reduce burnout. (prnewswire.com) ### Is this just one company, or a broader trend? It looks broader. Recent funding in senior-care and post-acute tech has gone toward platforms trying to make aging-in-place, home recovery, and long-term care operations less chaotic. Enzo fits that pattern, but with a narrower focus on the administrative machinery behind home health. In other words, this is less a consumer aging story than an infrastructure story. (prnewswire.com) ### Bottom line? Enzo’s raise matters because it is a bet that the next big home-health upgrade is not a new clinic model — it is better software for the agencies already doing the work. If that thesis holds, the winners in elder care may be the companies that make care-at-home less administratively miserable to deliver. (prnewswire.com) (homehealthcarenews.com)